Subscribe to:
AIDSmeds & POZ newsletters
POZ magazine
Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
Scientists Discover and Target HIV’s Weak Spot
Progressive Resistance Exercise Good for People With HIV
Hormonally Challenged
Montaner: Treat HIV to Help Curb Infection Spread
Ready to Quit? The Risks and Rewards of a Potent Smoking-Cessation Drug
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Herpes Simplex Virus
Syphilis & Neurosyphilis
Shingles
The HIV Life Cycle
Human Papilloma Virus (HPV)
Treatments for Opportunistic Infections (OIs)
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

February 6, 2006

Investigating Reports of Excessive False-Positive Oral Fluid Rapid HIV Tests

by Tim Horn

Over the past several months, there have been numerous mainstream media reports regarding an unusually high number of false-positive HIV-antibody test results using the oral-based OraQuick rapid assay (the reliability of the blood-based OraQuick assay hasn't been disputed). Dr. Bernard Branson and his colleagues at the U.S. Centers for Disease Control have investigated these reports and reported their findings at the 13th Conference on Retroviruses and Opportunistic Infections in Denver.

Dr. Branson's group looked at three testing sites in New York City that have reported excessive false-positives (cases), along with seven sites in the city that have not reported excessive false-positives (controls). And in San Francisco, his group looked at one site with excessive false-positive and 11 sites without excessive false-positive test results.

Using November 2005 as an example, 1581 individuals were tested throughout the month at one of the three case clinics in New York City. There were 32 false-positive rates in total, yielding a testing specificity of 98%. Among the seven control testing sites, 2164 people were tested in November. There were three false-positive test results, putting the specificity at 99.9%. In San Francisco during the same month, 160 oral-based tests were conducted at the case clinic, six of which turned out to be false-positive (yielding a specificity of 96.3%). In the 11 control clinics, 551 tests were conducted, with five false-positive test results (yielding a specificity of 99.1%).

The FDA minimum threshold for specificity is 98%. Dr. Branson's group concluded that the false-positive results are not likely a limitation of the oral-based test themselves, but rather attributed to site-specific factors, including the possibility of procedural errors. The CDC is still looking into the discrepancies.

Source: Branson B, Wesolowski L, Delaney K. et al. Investigation of reports of excessive false-positive oral fluid rapid HIV tests [Abstract 34LBb]. 13th Conference on Retroviruses and Opportunistic Infections, Denver, 2006.

emailrssprint


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Conference Coverage

XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


CROI 2008
Boston, MA
February 3-8, 2008


2007 National Prevention Conference
Atlanta
December 2-7, 2007


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]

© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy